Company news

Pacific Biosciences of California, Inc. news in 2024

Pacific Biosciences of California, Inc.'s news releases, calls and decks from 2024, newest first.

View company

PacBio Announces Third Quarter 2024 Financial Results

November 6, 2024

PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028

November 6, 2024

PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop

November 5, 2024

Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep

October 29, 2024

PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500

October 28, 2024

PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program

October 21, 2024

PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing

October 10, 2024

PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024

October 9, 2024

PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore

September 30, 2024

PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific

September 10, 2024

Revio to Power Research in Male Infertility and Rare Disease at Münster University Hospital

September 3, 2024

PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

August 25, 2024

PacBio Announces Second Quarter 2024 Financial Results

August 6, 2024

Singapore’s National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia

August 4, 2024

Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing

July 22, 2024

PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024

July 14, 2024

Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices

June 26, 2024

PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database

June 9, 2024

Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases

May 14, 2024

PacBio Announces First Quarter 2024 Financial Results

May 8, 2024

PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance

April 15, 2024

Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes

March 26, 2024

PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions

March 11, 2024

PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results

February 14, 2024

PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale

February 4, 2024

PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024

January 24, 2024

PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions

January 14, 2024

PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively

January 7, 2024

Calls in 2024

Decks in 2024